Locate Montgomery buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
Richard Alan Stehl, MD
P O Box 242522
Montgomery, AL 36124
Main Tel: 334-558-0908
|
Dr. Scott Alexander Bell, M.D.
138 Adams Ave. Suite 3
Montgomery, AL 36104
Main Tel: (334) 328-5574
|
Dr. Joseph Patrick Lucas, M.D.
4371 Narrow Lane Road
Montgomery, AL 36116
Main Tel: (334) 323-3307
|
Dr. Clemmie Lee Palmer, III, M.D.
3090 Woodley Road
Montgomery, AL 36116
Main Tel: (334) 280-3230
|
Dr. Gilberto Sanchez, M.D.
4143 Atlanta Highway
Montgomery, AL 36109
Main Tel: (334) 271-4503
|
DLivro L. Beauchamp, M.D.
4705 Woodmere Boulevard
Montgomery, AL 36106
Main Tel: (334) 558-0262
|
Dr. Gregory Philip Jones, D.O.
470 Taylor Road
Suite 300
Montgomery, AL 36117
Main Tel: (334) 281-1191
|
Dr. Shankar B. Yalamanchili, M.D.
233 Winton M Blount Loop
Montgomery, AL 36117
Main Tel: (334) 270-5502
|
Dr. Anil Pal Saini,
233 Winton M. Blount Loop
Montgomery, AL 36117
Main Tel: (334) 270-5502
|
Dr. Ramakanth K. Vemuluri,
7085 Sydney Curve
Montgomery, AL 36117
Main Tel: (334) 270-5502
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.